← FDA DRUG APPROVALS

FDA ANDA · ANDA040246

COMPRO

prochlorperazine

Sponsor: PADAGIS US

APPLICATION
ANDA040246
TYPE
ANDA
ORIGINAL APPROVAL
2000-06-28
LATEST ACTION
2025-01-22
ROUTE
RECTAL
DOSAGE FORM
SUPPOSITORY
MARKETING STATUS
Prescription

Products

COMPROPrescription
PROCHLORPERAZINE 25MG · SUPPOSITORY · RECTAL

Approval history

2025-01-22Labeling · Supplement 18 · standardAP
2017-02-23Labeling · Supplement 14 · standardAP
2011-10-25Labeling · Supplement 13AP
2010-12-03Labeling · Supplement 12AP
2009-07-07Labeling · Supplement 8AP
2009-03-03Labeling · Supplement 7AP
2008-05-15Labeling · Supplement 6AP
2001-02-09Manufacturing (CMC) · Supplement 1AP
2000-06-28OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →